Cheers to our colleagues as they start new roles at UW Medicine and as they move on to new chapters in their careers or retirement.
Here’s who is on the move:
John Amory
John Amory
John Amory, MD, will become the new principal investigator for the Institute of Translational Health Sciences, effective March 1, 2024.
Amory has been with the institute since its inception. He is a board-certified physician at the General Internal Medicine Center at UW Medical Center-Roosevelt. He is also a professor of Medicine and section head of General Internal Medicine at the UW School of Medicine. He has published more than 110 peer-reviewed papers in the field of male reproduction and holds current funding from a National Institutes of Health grant for contraceptive research. For the last several years, he’s been the leader of the Institute of Translational Health Sciences KL2 Multidisciplinary Clinical Research Career Development program, which provides the time, funding, mentorship, and training necessary to foster the early career development of clinical and translational researchers.
Read more in the press release from the Institute of Translational Health Sciences.
Nora Disis
Nora Disis
Mary “Nora” Disis, MD, principal investigator for the Institute of Translational Health Sciences will depart from her position on March 1, 2024. She will remain active in several other roles, including as director of the UW Medicine Cancer Vaccine Institute, where she is currently working on Phase 2 trials of a breast cancer vaccine.
Disis founded the Institute more than a decade ago, and in 2022, the Institute was granted over $63 million in funding over five years through a Clinical and Translational Science Award from the National Institutes of Health.
Disis also serves as the associate dean for Translational Health Sciences at the University of Washington School of Medicine, professor of Medicine and adjunct professor of Pathology and Obstetrics and Gynecology at UW School of Medicine, and a member of the Fred Hutchinson Cancer Center.
Read more in an Institute of Translational Health Sciences Interview: What’s next for Dr. Nora Disis to learn more about her professional shift to her work at the Cancer Vaccine Institute.
Chuck Murry
Chuck Murry
Charles “Chuck” Murry, MD, PhD, the director of the Institute for Stem Cell and Regenerative Medicine and a longtime faculty member at the University of Washington School of Medicine, has been appointed to lead stem-cell research at the University of Southern California’s Keck School of Medicine. He will start there in August.
Murry’s lab has focused on the potential of stem cell-derived heart muscle cells to regenerate living tissue that could help people recover from heart failure. A professor of laboratory medicine and pathology, bioengineering, and medicine (cardiology), Murry also has been recognized for his work as an outstanding teacher at the UW School of Medicine.
Read more on the UW Medicine Newsroom.
Ali Rowhani-Rahbar
Ali Rowhani-Rahbar
As of March 16, 2024, Ali Rowhani-Rahbar, MD, PhD, will serve as the director of the Firearm Injury & Policy Research Program. Rowhani-Rahbar has served as interim director since April 1, 2023, following Frederick Rivara, MD, who served as founding director from 2019-2023.
Rowhani-Rahbar is a national leader in firearm injury prevention, serving as a member of the board of directors for the National Research Society for the Prevention of Firearm-Related Harms and a member of the board of Scientific Counselors for the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention. In 2023, Rowhani-Rahbar was elected to the National Academy of Medicine in recognition of his research contributions to understanding the risk and consequences of firearm-related harm and informing policies and programs to reduce the risk of firearm-related harm, particularly in underserved communities.
